Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Biotech And Russell Bounce Off Critical Support Levels

Published 04/19/2019, 01:01 AM
Updated 09/20/2023, 06:34 AM

S&P 500 (SPY (NYSE:SPY))

Retail sales came in at 1.6% for March better than estimates of 0.8%. Also, GDPNow ticked up 2.8% for the second quarter from 2.3%. But on this over the weekend.

Stocks pieced together a solid day and what was best of all was that both the Rusell 2000 and the Biotech XBI gave a solid bounce at crucial support levels. Does that mean everything is fine and dandy for Monday? Not sure about that, but it is undoubtedly better than the alternative.

First and foremost the S&P 500 has now filled the gap at 2,891, and that should set up a much better week of April 22.

Russell (IWM)

The Russell fell briefly below support at 1565 but managed to reclaim it by days end.

Biotech (XBI)

Meanwhile, the XBI had a that solid bounce off of support around $82.

Square (NYSE:SQ)

Well, I think square has broken down, falling below support of the descending triangle — it setup up a further drop to around $68 and perhaps as low as $65.50.

Skyworks (NASDAQ:SWKS)

Skyworks fell back to $90 and could drop back to support around $88 after failing at resistance at $93. The longer-term trend is still higher.

JD (JD)

JD.com looks like it is getting ready to make its next big move higher with $35 as the target.

Microsoft (NASDAQ:MSFT)

Microsoft continues to go, and I still think $127 is in its future.

Original post

Latest comments

Would Biotech contine to draft lower ?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.